3-D Matrix Ltd. engages in the research, development, manufacture, and sale of medical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 106 full-time employees. The company went IPO on 2011-10-24. The firm has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.
Follow-Up Questions
What is the price performance of DMTRF stock?
The current price of DMTRF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for 3-D Matrix Ltd?
3-D Matrix Ltd belongs to Biotechnology industry and the sector is Health Care
